Business Context and Reporting Period
This Form 8-K is filed by HAPC, Inc. (noting the metadata reference to Infusystem Holdings, Inc. likely refers to the target, InfuSystem, Inc.) for the reporting period of September 12, 2007. The filing discloses the entry into a non-binding Memorandum of Intent (MOI) regarding the proposed acquisition of InfuSystem, Inc. by HAPC, Inc.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity for the reporting period. The document focuses exclusively on the terms of a proposed transaction.
- Original Purchase Price: $140,000,000
- Proposed Reduced Purchase Price: $100,000,000
- Maximum Contingent Consideration: $12,000,000
Material Changes
The primary material change is the negotiation to amend the existing Stock Purchase Agreement dated September 29, 2006. The proposed amendment reduces the upfront cash consideration payable by HAPC to I-Flow Corporation (the seller) from $140 million to $100 million. This reduction is offset by the introduction of contingent consideration.
Guidance, Outlook, and Risks
Transaction Structure: The MOI contemplates a reduction in the upfront payment with the addition of contingent consideration payable in 2011. This payment is based on the compound annual growth rate (CAGR) of HAPC's consolidated revenues over the three-year period ending December 31, 2010.
Performance Target: The maximum contingent amount of $12 million would be payable if HAPC achieves a 50% CAGR over the specified three-year period.
Status and Risks: The amendment has not yet been executed. The transaction remains subject to the execution of the amended agreement and the distribution of a supplemental proxy statement to stockholders. The filing notes that the description of the MOI is not complete and refers to the full text of the exhibit.
Investor Verification Checklist
- Verify the execution status of the amended Stock Purchase Agreement.
- Review the full text of the Memorandum of Intent (Exhibit 10.1) for specific conditions related to InfuSystem's operations required to trigger contingent payments.
- Confirm the terms of the supplemental proxy statement to be distributed to stockholders of record as of August 6, 2007.
- Assess the feasibility of HAPC achieving a 50% compound annual revenue growth rate through 2010 to determine the likelihood of the $12 million contingent payout.